ASO Author Reflections: Changes in Use of Neoadjuvant Chemotherapy Over Time—Highest Rates of Use Now in Triple-Negative and HER2+ Disease

Brittany L. Murphy, Judy C. Boughey

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'ASO Author Reflections: Changes in Use of Neoadjuvant Chemotherapy Over Time—Highest Rates of Use Now in Triple-Negative and HER2+ Disease'. Together they form a unique fingerprint.